Advances In Biotechnology Research Articles

Insight into metabolic dysregulation of polycystic ovary syndrome utilizing metabolomic signatures: a narrative review.

Polycystic ovary syndrome (PCOS) is a complex multifactorial endocrinopathy affecting reproductive aged women globally, whose presentation is strongly influenced by genetic makeup, ethnic, and geographic diversity leaving these affected women substantially predisposed to reproductive and metabolic perturbations. Sophisticated techniques spanning genomics, proteomics, epigenomics, and transcriptomics have been harnessed to comprehensively understand the enigmatic pathophysiology of PCOS, however, conclusive markers for PCOS are still lacking today. Metabolomics represents a paradigm shift in biotechnological advances enabling the simultaneous identification and quantification of metabolites and the use of this approach has added yet another dimension to help unravel the strong metabolic component of PCOS. Reports dissecting the metabolic signature of PCOS have revealed disparate levels of metabolites such as pyruvate, lactate, triglycerides, free fatty acids, carnitines, branched chain and essential amino acids, and steroid intermediates in major biological compartments. These metabolites have been shown to be altered in women with PCOS overall, after phenotypic subgrouping, in animal models of PCOS, and also following therapeutic intervention. This review seeks to supplement previous reviews by highlighting the aforementioned aspects and to provide easy, coherent and elementary access to significant findings and emerging trends. This will in turn help to delineate the metabolic plot in women with PCOS in various biological compartments including plasma, urine, follicular microenvironment, and gut. This may pave the way to design additional studies on the quest of unraveling the etiology of PCOS and delving into novel biomarkers for its diagnosis, prognosis and management.

Periprosthetic joint infections: state-of-the-art.

In general, periprosthetic joint infection (PJI) is regarded as one of the most common complications of total joint arthroplasty (TJA) and may lead to surgical failure, revision surgery, amputation or death. Nowadays, PJI has become a global health concern, which brings a great burden to public healthcare. In addition, there are still obstacles to achieve high success rates in the prevention, diagnosis and treatment of PJI. However, promising studies are also available with the advancements in biotechnology. This article will present an overview of the current methods used in the prevention, diagnosis and management of PJI while underlining the new technologies utilized.

Hydrogel models of pancreatic adenocarcinoma to study cell mechanosensing

AbstractPancreatic adenocarcinoma (PDAC) is the predominant form of pancreatic cancer and one of the leading causes of cancer-related death worldwide, with an extremely poor prognosis after diagnosis. High mortality from PDAC arises partly due to late diagnosis resulting from a lack of early-stage biomarkers and due to chemotherapeutic drug resistance, which arises from a highly fibrotic stromal response known as desmoplasia. Desmoplasia alters tissue mechanics, which triggers changes in cell mechanosensing and leads to dysregulated transcriptional activity and disease phenotypes. Hydrogels are effective in vitro models to mimic mechanical changes in tissue mechanics during PDAC progression and to study the influence of these changes on mechanosensitive cell responses. Despite the complex biophysical changes that occur within the PDAC microenvironment, carefully designed hydrogels can very closely recapitulate these properties during PDAC progression. Hydrogels are relatively inexpensive, highly reproducible and can be designed in a humanised manner to increase their relevance for human PDAC studies. In vivo models have some limitations, including species-species differences, high variability, expense and legal/ethical considerations, which make hydrogel models a promising alternative. Here, we comprehensively review recent advancements in hydrogel bioengineering for developing our fundamental understanding of mechanobiology in PDAC, which is critical for informing advanced therapeutics.

Abstract A001: Navigating the future of therapeutic development: innovations in safety and efficacy through advanced research methodologies and nanotechnology

Abstract In recent years, the field of therapeutic development has experienced a significant paradigm shift driven by strategic scientific innovations that prioritize safety and efficacy in therapeutic agents. This paper explores the intersection of advanced research methodologies, novel material sciences, and biotechnological advancements that are revolutionizing the approach to drug formulation and delivery systems. The integration of precision medicine principles alongside cutting-edge technologies allows for the design of therapeutics that are not only effective in targeting specific diseases but are also engineered to minimize adverse effects associated with conventional therapies. One focal point of this exploration is the application of nanotechnology in drug delivery systems. By utilizing nanoparticles, researchers can enhance the bioavailability of therapeutic agents while reducing systemic toxicity. This targeted approach enables the delivery of higher concentrations of drugs to the affected areas, thereby maximizing therapeutic efficacy and minimizing side effects. Additionally, the paper highlights the role of computational modeling and simulations in predicting the interaction of therapeutic agents at the molecular level, facilitating the identification of safer compounds through virtual screening methods. Another significant aspect addressed in this paper is the development of biologics and biosimilars as safer alternatives to traditional synthetic drugs. The advancement of biomanufacturing processes has made it feasible to produce complex molecules with high specificity and reduced immunogenicity, paving the way for innovative therapies that cater to individual patient profiles. Furthermore, the strategic incorporation of pharmacogenomics in drug development allows for the customization of therapeutic agents, ensuring that treatment regimens are tailored to the genetic makeup of patients, which can drastically improve safety and treatment outcomes. The paper also discusses the regulatory landscape surrounding the introduction of these innovative therapeutic agents. It emphasizes the need for adaptive regulatory frameworks that keep pace with scientific advancements while ensuring patient safety and efficacy. Collaborative efforts between researchers, regulatory bodies, and pharmaceutical companies are essential to facilitate the translation of innovative therapies from the laboratory to clinical practice. In conclusion, this paper underscores the critical importance of strategic scientific innovations in the quest for safer therapeutic agents. By harnessing the potential of advanced technologies, researchers can develop therapeutics that not only meet the growing demand for efficacy but also uphold the highest standards of safety, ultimately improving patient care and health outcomes. The findings presented advocate for continued investment in research and collaboration across disciplines to drive future advancements in therapeutic development. Citation Format: Peter O. David. Navigating the future of therapeutic development: innovations in safety and efficacy through advanced research methodologies and nanotechnology. [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Optimizing Therapeutic Efficacy and Tolerability through Cancer Chemistry; 2024 Dec 9-11; Toronto, Ontario, Canada. Philadelphia (PA): AACR; Mol Cancer Ther 2024;23(12_Suppl):Abstract nr A001

The Rise of Plant-Based and Fermented Drinks: Shaping the Beverage Industry in the Next Decade

This article explores the growing demand for plant-based and fermented beverages, highlighting key drivers, consumer motivations, and the future of the beverage industry. With health and environmental awareness on the rise, plant-based and fermented drinks are poised to become staple categories in the market. This trend is catalyzing innovation, impacting consumer preferences, and transforming product offerings. Analyzing current market data, case studies, and consumer behavior, this article discusses how these beverages could dominate menus and retail shelves in the coming years. Keywords: Plant, Fermented Drinks, Probiotic, Low Sugar Alternatives, Alternative Protein Sources, Biotechnological advancements, Low- ABV Drinks, Market Expansion.

Antibacterial, Antifungal, Antiviral Activity, and Mechanisms of Action of Plant Polyphenols

This review describes the enhanced classification of polyphenols into flavonoids, lignans, phenolic acids, stilbenes, and tannins. Its focus is the natural sources of polyphenols and an in-depth discussion of their antibacterial, antifungal, and antiviral activity. Besides a broad literature overview, this paper contains authors’ experimental data according to some daily consumed vegetables such as tomatoes, different varieties of onion, garlic, parsley, and cayenne pepper and the probable relation of these activities to polyphenols. The isolation of polyphenols via conventional and ultrasonic, pressurized liquids and pulse-field extractions, as well as their methods for detection and determination, are interpreted as well. The main mechanisms by which polyphenols inhibit the growth of bacteria, fungi, and viruses, such as protein synthesis, cell membrane destabilization, and ROS production induction, are in focus. Data on polyphenol concentrations and their respective MIC or the inhibition zone diameters of different bacterial and fungal species and suppressing viral replication are depicted. The toxicity of polyphenols in vitro, ex vivo, and in vivo towards microorganisms and human/animal cells, and the safety of the polyphenols applied in clinical and industrial applications are expanded. This review also characterizes the antimicrobial effects of some chemically synthesized polyphenol derivatives. Biotechnological advances are also reported, especially the entrapment of polyphenols in biocompatible nanoparticles to enhance their bioavailability and efficacy. Polyphenols are promising for exploring molecules’ novel antimicrobial substances and paving the path for effective novel antimicrobial agents’ discovery, taking into consideration their positives and negatives.

Biotechnological progresses in modelling the human endometrium: the evolution of current in vitro techniques and emerging trends.

The endometrium plays a fundamental role in the reproductive system yet many etiologies of infertility-related endometrial diseases such as endometriosis, adenomyosis, Asherman's syndrome or endometrial cancer remain unknown. There are currently no treatments that minimize the effects of this devastating disorder. Appropriate model systems that closely mimic the architecture and function of the endometrium in healthy and pathological states are needed to understand the underlying molecular pathways and develop novel or more effective treatments. This review summarizes the key milestones of in vitro culture models of the human endometrium throughout history, as well as the applications of advanced bioengineering techniques in the modelling of both healthy and pathological endometrium. Opportunities for future approaches are also discussed.

Biotechnology Advances in Natural Food Colorant Acylated Anthocyanin Production

ABSTRACTThe food application of natural blue colorants such as acylated anthocyanin is becoming increasingly popular due to their safety, nutritional value, organoleptic attributes, and more pH/thermo‐stable properties compared to nonacylated anthocyanins. However, it is a great challenge to obtain enough acylated anthocyanins to meet market demand, rather than readily available in nature from edible fruits and vegetables. In this review, the acylated anthocyanins in food crops, the efficient and eco‐friendly extraction of food‐grade acylated anthocyanins, and their potential application in intelligent packaging are extensively summarized. Subsequently, the plant anthocyanin acyltransferases (AATs) are also comprehensively summarized. The strategy of functional optimization of AATs through computational or artificial intelligence–based protein‐directed evolution is described and suggested. Additionally, the advantages and disadvantages of acylated anthocyanins generated in microbes and plant suspension cells are extensively compared, and the chassis selection of engineering acylated anthocyanins is discussed. Finally, the approaches and strategies of metabolic engineering to enhance the yield of acylated anthocyanins in plant suspension cells are also described and discussed. Taken together, this review provides a roadmap or strategy for the production of acylated anthocyanins to meet the increasing market demand in future food industry.

Recent advances in HPV biotechnology: understanding host-virus interactions and cancer progression – a review

Cervical cancer ranks as the fourth most common cancer among women globally, posing a significant mortality risk. Persistent infection with high-risk human papillomavirus (HPV) is the primary instigator of cervical cancer development, often alongside coinfection with other viruses, precipitating various malignancies. This study aimed to explore recent biotechnological advances in understanding HPV infection dynamics, host interactions, and its role in oncogenesis. The gathered data shed light on HPV biology, host-virus interplay, viral coinfections, and cellular transformations leading to HPV-associated cancers. Recent years have seen the introduction of diverse vaccination strategies, including live attenuated, subunit, and DNA-based vaccines, complemented by innovative nanotechnology and plant-based products. Despite rich data addressing research inquiries, urgent calls echo for the implementation of contemporary screening and therapeutic modalities at clinical levels. Moreover, extensive public awareness campaigns are imperative to alleviate the burden of HPV-related diseases, emphasizing the necessity for proactive intervention strategies in combating this global health challenge.

Advances in microalgal biotechnology in Costa Rica: contributions from the Costa Rica Institute of Technology

Advances in microalgal biotechnology in Costa Rica: contributions from the Costa Rica Institute of Technology

Biotechnological Advances in Vanillin Production: From Natural Vanilla to Metabolic Engineering Platforms

Vanillin, an aromatic aldehyde, is one of the most popular flavors worldwide, extensively used in the food, cosmetics, pharmaceutical, and agrochemical industries. Despite its widespread use, less than 1% of the total vanillin production is natural, with the majority being synthesized chemically. While chemical synthesis can help to meet the growing demand for vanillin, a strong market trend has rapidly developed for products created from natural ingredients, including natural vanillin. Given the labor-intensive process of extracting vanillin from vanilla pods, there is a critical need for new metabolic engineering platforms to support the biotechnological production of nature-identical vanillin. This review highlights the significance of vanillin in various markets, its diverse applications, and the current state of bio-engineered production using both prokaryotic and eukaryotic biological systems. Although recent advancements have demonstrated successful vanillin production through biocatalytic approaches, our focus was to provide a current and innovative overview of vanillin bioengineering across various host systems with special consideration placed on microalgae, which are emerging as promising platforms for vanillin production through metabolic engineering. The use of these systems to support the biotechnological production of vanillin, while leveraging the photosynthetic capabilities of microalgae to capture CO2 and convert it into biomass, can significantly reduce the overall carbon footprint.

Vaccines in the Era of Emerging Infectious Diseases: Immune Mechanisms and Innovations

Emerging infectious diseases (EIDs) continue to challenge global public health, driven by factors like climate change, urbanization, and increasing human-animal interactions. The rapid spread of the COVID-19 pandemic highlighted the need for swift vaccine development and deployment. Vaccines remain one of the most effective public health tools, capable of preventing disease outbreaks by inducing immunity through humoral and cell-mediated mechanisms. Recent advancements in immunology and biotechnology have revolutionized vaccine development, enabling the creation of new platforms such as mRNA vaccines, viral vectors, and nanoparticle-based vaccines. These innovations allow for faster production, greater efficacy, and adaptability to novel pathogens. Additionally, new delivery methods, including microneedle patches and nasal sprays, aim to improve accessibility and ease of administration, particularly in low-resource settings. However, challenges such as vaccine equity, distribution logistics, and public hesitancy must be addressed to ensure broad and effective vaccination coverage. This review explores the immune mechanisms of vaccines, current vaccine technologies, and emerging innovations to address EIDs, with a focus on future preparedness for pandemics. Keywords: Emerging infectious diseases, vaccines, mRNA technology, nanoparticle vaccines, immune mechanisms, vaccine innovations

Post-spin Stretch Improves Mechanical Properties, Reduces Necking, and Reverts Effects of Aging in Biomimetic Artificial Spider Silk Fibers.

Recent biotechnological advancements in protein production and development of biomimetic spinning procedures make artificial spider silk a promising alternative to petroleum-based fibers. To enhance the competitiveness of artificial silk in terms of mechanical properties, refining the spinning techniques is imperative. One potential strategy involves the integration of post-spin stretching, known to improve fiber strength and stiffness while potentially offering additional advantages. Here, we demonstrate that post-spin stretching not only enhances the mechanical properties of artificial silk fibers but also restores a higher and more uniform alignment of the protein chains, leading to a higher fiber toughness. Additionally, fiber properties may be reduced by processes, such as aging, that cause increased network entropy. Post-spin stretching was found to partially restore the initial properties of fibers exposed aging. Finally, we propose to use the degree of necking as a simple measure of fiber quality in the development of spinning procedures for biobased fibers.

Exploring Microbial Dark Matter for the Discovery of Novel Natural Products: Characteristics, Abundance Challenges and Methods.

The objective of this review is to investigate microbial dark matter (MDM) with a focus on its potential for discovering novel natural products. This first part will examine the characteristics and abundance of these previously unexplored microbial communities, as well as the challenges faced in identifying and harnessing their unique biochemical properties and novel methods in this field. MDMs are thought to hold great potential for the discovery of novel natural products, which could have significant applications in medicine, agriculture, and industry. In recent years, there has been a growing interest in exploring microbial dark matter to unlock its potential. In fact, developments in genome-sequencing technologies and sophisticated phylogenetic procedures and metagenomic techniques have contributed to drastically make important changes in our sights on thediversity of microbial life, including the very outline of the tree of life. This has led to the development of novel technologies and methodologies for studying these elusive microorganisms, such as single-cell genomics, metagenomics, and culturomics. These approaches enable researchers to isolate and analyze individual microbial cells, as well as entire communities, providing insights into their genetic and metabolic potential. By delving into the microbial dark matter, scientists hope to uncover new compounds and biotechnological advancements that could have far-reaching impacts on various fields.

Frederick G Banting (1891-1941): A Pioneer in Diabetes Treatment.

The discovery of insulin by Frederick G Banting and his colleagues in 1921 marked a pivotal moment in medical history. Born in Ontario, Canada, in 1891, Banting's childhood was impacted by the death of his closest friend, Jane, who died of diabetes mellitus at a young age. This personal tragedy profoundly influenced him to choose a career in medicine and fueled his determination to find a cure for diabetes. This journey led to the discovery of Insulin with the help of Charles H Best and John JR Macleod, resulting in a Nobel Prize for this work. Their discoveries set the stage for advancements in clinical medicine and biotechnology, including developing recombinant insulin over 50 years later.

The Impact of Biotechnology in Shaping the Modern Agriculture

Advances in biotechnology have created new opportunities for food diversity in terms of both quantity and quality, as well as for collecting food in proportion to the world's expanding population and ensuring food security. With the advancement of molecular biology, DNA sequencing, and recombinant DNA in the middle of the 20th century, modern-day advancement of molecular breeding gave rise to genetic engineering and recombinent DNA techniques that are today frequently connected to biotechnology. This expansion has been facilitated by a variety of fields, including genetics, molecular biology, and biotechnology. The use of genetic engineering in agriculture has grown due to its ability to precisely create and insert a gene from any living organism. Molecular markers are also utilized to identify disease and pest resistance in order to increase agricultural output using traditional techniques. Genetic engineering plays a crucial role in agriculture, representing the scientific and technical advancement of traditional methods for crop enhancement. Recombinant DNA technology, RNA interference, and CRISPR genomic editing are some of the instruments and methods used in genetic engineering. The emergence of biotechnological innovations aimed at improving the nutritional composition of individual foods has led to the growing problem of a malnourished world population, where a growing number of people rely on large regions of the world for food used as the only source of protein, carbohydrates, fats and several essential minerals and vitamins, in addition to being a source of energy.

AI-enabled exploration of the "dark matter" of the protein universe

Abstract. The "dark matter" of the protein universe, consisting of proteins lacking structural information or functional annotations, represents a significant challenge in understanding the complexity of life. Recent breakthroughs in artificial intelligence (AI), particularly in protein structure prediction, have revolutionized our ability to illuminate this uncharted territory. AI-based methods such as AlphaFold and RoseTTAFold can predict protein structures with unprecedented accuracy and scale, while large-scale databases provide access to the predicted structural models for hundreds of millions of proteins. Leveraging these AI tools and databases, researchers can uncover novel protein families, folds, and functions, and even design new proteins, paving the way for advances in basic biology, biotechnology, and medicine. This review discusses the recent progress of AI-enabled exploration of the "dark matter" of the protein universe, highlights recent advancements, and outlines future challenges and opportunities in this field.

Advances in wearable biotechnology for cardiac monitoring

Wearable biotechnology is enhancing cardiac health monitoring by enabling continuous data collection for early detection and better management of cardiovascular diseases (CVDs). Recent advancements, such as multi-sensor integration, combine electrocardiography (ECG), heart rate variability, blood pressure, and oxygen saturation monitoring to provide a comprehensive cardiovascular assessment and improve diagnostic precision. Innovations in energy-harvesting technologies, like thermoelectric and piezoelectric materials, extend battery life, reducing the need for frequent recharging and increasing patient adherence. Despite these advances, challenges remain, particularly concerning data security, which requires robust encryption methods and secure data transmission protocols. Regulatory frameworks like the GDPR and HIPAA need to evolve to accommodate technological progress, ensuring new devices are safe and quickly brought to market. Enhancing interoperability with electronic health records (EHRs) is crucial to maximizing the clinical utility of wearable devices. Future research should focus on developing biochemical sensors to detect specific biomarkers in bodily fluids, refining AI algorithms for personalized diagnostics, and establishing standards for data sharing and integration. Collaboration among healthcare providers, regulatory bodies, and technology developers is essential to overcoming current barriers, expanding clinical applications, and ultimately improving patient outcomes and public health.

Essential Oils of Neotropical Myrtaceae Species from 2011 until 2023: An Update.

The Myrtaceae family is renowned for its rich diversity of bioactive metabolites with broad applications across various industries. This review comprehensively explores the chemical composition and biological activities of Neotropical species within the Myrtaceae family from 2011 to 2023. A total of 170 papers were analyzed, covering 148 species from 28 genera, with notable emphasis on Eugenia, Eucalyptus, Myrcia, and Psidium. Compounds with relative abundance exceeding 10% were tabulated to highlight the most significant volatiles for each genus. Our findings were cross-referenced with previous reviews whenever feasible. Antioxidant, antibacterial, and antimicrobial activities emerged as the primary focus, collectively representing 41% of the studies, predominantly conducted in vitro. Additionally, we discuss less conventional approaches to essential oil studies in Myrtaceae species, underscoring avenues for future exploration. The investigation of essential oils from Myrtaceae holds promise for significant advancements in biotechnology, with potential benefits for the economy, environment, and human health. This review serves as a valuable resource for guiding future research strategies in this field.

Bioengineered therapeutic systems for improving antitumor immunity

Abstract Immunotherapy, a monumental advancement in antitumor therapy, still yields limited clinical benefits owing to its unguaranteed efficacy and safety. Therapeutic systems derived from cellular, bacterial, and viral sources possess inherent properties that are conducive to antitumor immunotherapy. However, crude biomimetic systems have restricted functionality and may produce undesired toxicity. With the advances in biotechnology, various toolkits are available to add or subtract certain properties of living organisms to create flexible therapeutic platforms. This review elaborates on the creation of bioengineered systems by gene editing, synthetic biology, and surface engineering to enhance immunotherapy. The modifying strategies on the systems are discussed, including equipment of navigation and recognition systems to improve therapeutic precision, introduction of controllable components to control the duration and intensity of treatment, addition of immunomodulatory components to amplify immune activation, and removal of toxicity factors to ensure biosafety. Finally, we summarize the advantages of bioengineered immunotherapeutic systems and possible directions for their clinical translation.